Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)'s financial review
Employees
6
Total Funding
14.9M
Last Funding Round
7.5M
nasdaq
CVKD
Market cap
6.6M
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) information
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) industries
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)'s financial review
Employees
6
Total Funding
14.9M
Last Funding Round
7.5M
nasdaq
CVKD
Market cap
6.6M
Employee Metrics
Technologies
Employees
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
CEO, Victorious